Journal of Thrombosis and Thrombolysis

Aims & Scope

The Journal of Thrombosis and Thrombolysis is a long-awaited resource for contemporary cardiologists, hematologists, vascular medicine specialists and clinician-scientists actively involved in treatment decisions and clinical investigation of thrombotic disorders involving the cardiovascular and cerebrovascular systems.

The principal focus of the Journal centers on the pathobiology of thrombosis and vascular disorders and the use of anticoagulants, platelet antagonists, cell-based therapies and interventions in scientific investigation, clinical-translational research and patient care.

The Journal will publish original work which emphasizes the interface between fundamental scientific principles and clinical investigation, stimulating an interdisciplinary and scholarly dialogue in thrombosis and vascular science.

Published works will also define platforms for translational research, drug development, clinical trials and patient-directed applications.

The Journal of Thrombosis and Thrombolysis' integrated format will expand the reader's knowledge base and provide important insights for both the investigation and direct clinical application of the most rapidly growing fields in medicine-thrombosis and vascular science.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.2
2024	2.30

Journal Rank

Year	Value
2024	7606

Journal Citation Indicator

Year	Value
2024	1441

SJR (SCImago Journal Rank)

Year	Value
2024	0.736

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	83

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The epidemiology of venous thromboembolism

  Citation: 831

  Authors: John A., Frederick A., Richard H.

• COVID-19 update: Covid-19-associated coagulopathy

  Citation: 516

  Authors: Richard C.

• Streptokinase and heparin versus heparin alone in massive pulmonary embolism: A randomized controlled trial

  Citation: 357

  Authors: Carlos, Alicia, María, Roberto, Salvador, Alfonso, Juan A., Emma

• Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum

  Citation: 347

  Authors: Geoffrey D., Allison, Arthur, Marilyn, Nathan P., Adam, William E., Steven B., Stacy, David, Scott, Tracy

• Guidance for the treatment and prevention of obstetric-associated venous thromboembolism

  Citation: 275

  Authors: Shannon M., Saskia, Marc, Andra H., Ian

• Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment

  Citation: 274

  Authors: Allison E., Charles E., Sara R., Lynn B., David A., Jack

• Guidance for the evaluation and treatment of hereditary and acquired thrombophilia

  Citation: 266

  Authors: Scott M., Scott C., Kenneth A., Raj, Mary, Michael, Wendy, James D.

• Guidance for the treatment of deep vein thrombosis and pulmonary embolism

  Citation: 253

  Authors: Michael B., Giancarlo, Jean M., Mark, Sabine, Renato, Robert D., Stephan, Jack

• COVID-19-associated vasculitis and vasculopathy

  Citation: 239

  Authors: Richard C.

• Incidence and cost burden of post-thrombotic syndrome

  Citation: 236

  Authors: Aneel A., John A.

---